Effects of aging on time course of neovascularization-related gene expression following acute hindlimb ischemia in mice

Chinese Medical Journal

Volumn 124, Issue 7, 2011, Pages 1075-1081

  Wang, Jin Song ^a,b   Liu, Xia ^a   Xue, Zhen Yi ^a   Alderman, Lee ^a   Tilan, Justin U ^a   Adenika, Remi ^a   Epstein, Stephen E ^a   Burnett, Mary Susan ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Age; Bone marrow; Ischemia; Molecular expression; Neovascularization; Time course

Indexed keywords

ANGIOPOIETIN 1; CD133 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

AGING; ANIMAL TISSUE; ARTICLE; BLOOD SMEAR; BONE MARROW; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; HINDLIMB; LEUKOCYTE COUNT; LIMB ISCHEMIA; MOUSE; MUSCLE NECROSIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL MOBILIZATION; UPREGULATION; WESTERN BLOTTING;

AGING; ANIMALS; BLOTTING, WESTERN; CHEMOKINE CXCL12; FEMALE; HINDLIMB; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIA; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NECROSIS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 79954531754     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.07.023     Document Type: Article

References (31)

1. Kinnaird T, Stabile E, Zbinden S, Burnett MS, Epstein SE. Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions. Cardiovasc Res 2008; 78: 257-264.
2. Sadoun E, Reed MJ. Impaired angiogenesis in aging is associated with alterations in vessel density, matrix composition, inflammatory response, and growth factor expression. J Histochem Cytochem 2003; 51: 1119-1130.
3. Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, et al. Age-dependent impairment of angiogenesis. Circulation 1999; 99: 111-120.
4. Chang EI, Loh SA, Ceradini DJ, Chang EI, Lin SE, Bastidas N, et al. Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1alpha stabilization during ischemia. Circulation 2007; 116: 2818-2829.
5. Hoffmann J, Haendeler J, Aicher A, Rössig L, Vasa M, Zeiher AM, et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 2001; 89: 709-715.
6. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM. Mouse model of angiogenesis. Am J Pathol 1998; 152: 1667-1679.
7. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004; 94: 678-685.
8. Carter WO, Bull C, Bortolon E, Yang L, Jesmok GJ, Gundel RH. A murine skeletal muscle ischemia-reperfusion injury model: differential pathology in BALB/c and DBA/2N mice. J Appl Physiol 1998; 85: 1676-1683.
9. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995; 77: 863-868.
10. Hickey MM, Simon MC. Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr Top Dev Biol 2006; 76: 217-257.
11. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 2006; 12: 557-567.
12. Lennmyr F, Ata KA, Funa K, Olsson Y, Terent A. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J Neuropathol Exp Neurol 1998; 57: 874-882.
13. Luque CD, Vargas RH, Romo E, Rios A, Escalante B. The role of nitric oxide in the post-ischemic revascularization process. Pharmacol Ther 2006; 112: 553-563.
14. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003; 9: 1370-1376.
15. Hao Q, Liu J, Pappu R, Su H, Rola R, Gabriel RA, et al. Contribution of bone marrow-derived cells associated with brain angiogenesis is primarily through leukocytes and macrophages. Arterioscler Thromb Vasc Biol 2008; 28: 2151-2157.
16. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem 1999; 274: 6519-6525.
17. Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 2001; 7: 345-350.
18. Bosch-Marce M, Okuyama H, Wesley JB, Sarkar K, Kimura H, Liu YV, et al. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 2007; 101: 1310-1318.
19. Babiak A, Schumm AM, Wangler C, Loukas M, Wu J, Dombrowski S, et al. Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion. Cardiovasc Res 2004; 61: 789-795.
20. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De MM, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7: 575-583.
21. Pipp F, Heil M, Issbrucker K, Ziegelhoeffer T, Martin S, van den HJ, et al. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ Res 2003; 92: 378-385.
22. Zhou YF, Stabile E, Walker J, Shou M, Baffour R, Yu Z, et al. Effects of gene delivery on collateral development in chronic hypoperfusion: diverse effects of angiopoietin-1 versus vascular endothelial growth factor. J Am Coll Cardiol 2004; 44: 897-903.
23. Shen BQ, Lee DY, Zioncheck TF. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem 1999; 274: 33057-33063.
24. Qian HS, de Resende MM, Beausejour C, Huw LY, Liu P, Rubanyi GM, et al. Age-dependent acceleration of ischemic injury in endothelial nitric oxide synthase-deficient mice: potential role of impaired VEGF receptor 2 expression. J Cardiovasc Pharmacol 2006; 47: 587-593.
25. Babaei S, Teichert-Kuliszewska K, Zhang Q, Jones N, Dumont DJ, Stewart DJ. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am J Pathol 2003; 162: 1927-1936.
26. Christopherson KW, Cooper S, Broxmeyer HE. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood 2003; 101: 4680-4686.
27. Christopherson KW, Hangoc G, Broxmeyer HE. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol 2002; 169: 7000-7008.
28. Yu Y, Flint A, Dvorin EL, Bischoff J. AC133-2, a novel isoform of human AC133 stem cell antigen. J Biol Chem 2002; 277: 20711-20716.
29. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-3972.
30. Cai W, Vosschulte R, fsah-Hedjri A, Koltai S, Kocsis E, Scholz D, et al. Altered balance between extracellular proteolysis and antiproteolysis is associated with adaptive coronary arteriogenesis. J Mol Cell Cardiol 2000; 32: 997-1011.
31. Pruijt JF, Fibbe WE, Laterveer L, Pieters RA, Lindley IJ, Paemen L, et al. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc Natl Acad Sci U S A 1999; 96: 10863-10868.